Jay T. Backstrom
- Hematology top 0.2%
- Acute Myeloid Leukemia Research 33
- Multiple Myeloma Research and Treatments 8
- Chronic Myeloid Leukemia Treatments 6
- Genetics top 0.5%
- Myeloproliferative Neoplasms: Diagnosis and Treatment 16
- Hemoglobinopathies and Related Disorders 9
- Chronic Lymphocytic Leukemia Research 8
- Molecular Biology top 5%
- Histone Deacetylase Inhibitors Research 5
- Emergency Medicine top 5%
-
- Pneumocystis jirovecii pneumonia detection and treatment 7
- Co-authors
- David R. McKenzieLewis R. SilvermanPierre FenauxAlan F. ListEva Hellström‐LindbergValeria SantiniGhulam J. MuftiJohn F. Seymour
- Cited by
- HematologyGeneticsMolecular Biology
- Partner nations
- United StatesFranceUnited Kingdom
In The Last Decade
Jay T. Backstrom
46 papers receiving 3.7k citations
Hit Papers
Peers
Comparison fields: 5 of 86
- Hematology 3.2k
- Genetics 1.0k
- Molecular Biology 1.7k
- Public Health, Environmental and Occupational Health 638
- Emergency Medicine 146
Countries citing papers authored by Jay T. Backstrom
This map shows the geographic impact of Jay T. Backstrom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jay T. Backstrom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jay T. Backstrom more than expected).
Fields of papers citing papers by Jay T. Backstrom
This network shows the impact of papers produced by Jay T. Backstrom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jay T. Backstrom. The network helps show where Jay T. Backstrom may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jay T. Backstrom, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 6 | |
| 2 | 2021 | 13 | |
| 3 | 2014 | 97 | |
| 4 | 2013 | 4 | |
| 5 | 2012 | 52 | |
| 6 | 2011 | 2 | |
| 7 | 2010 | 93 | |
| 8 | 2010 | 86 | |
| 9 | 2010 | 54 | |
| 10 | Azacitidine Prolongs Overall Survival Compared With Conventional Care Regimens in Elderly Patients With Low Bone Marrow Blast Count Acute Myeloid Leukemiabreakdown → | 2009 | 698 |
| 11 | 2009 | 8 | |
| 12 | Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III studybreakdown → | 2009 | 1756 |
| 13 | 2008 | 1 | |
| 14 | 2008 | 4 | |
| 15 | 2007 | 14 | |
| 16 | 2006 | 2 | |
| 17 | 2006 | 419 | |
| 18 | 2005 | 2 | |
| 19 | 2005 | 4 | |
| 20 | Aberrant regulation of ornithine decarboxylase by serum, putrescine, and spermidine in cytomegalovirus-transformed human cells. | 1979 | 7 |
About Jay T. Backstrom
Jay T. Backstrom is a scholar working on Hematology, Genetics, Toxicology, Geriatrics and Gerontology and Epidemiology, having authored 46 papers that have together received 3.8k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (33 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (16 papers), Hemoglobinopathies and Related Disorders (9 papers), Chronic Lymphocytic Leukemia Research (8 papers), Multiple Myeloma Research and Treatments (8 papers), Pneumocystis jirovecii pneumonia detection and treatment (7 papers), Chronic Myeloid Leukemia Treatments (6 papers) and Histone Deacetylase Inhibitors Research (5 papers). The work is most often cited by research in Hematology (3.2k citations), Genetics (1.0k citations), Molecular Biology (1.7k citations), Public Health, Environmental and Occupational Health (638 citations) and Emergency Medicine (146 citations). Jay T. Backstrom has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include David R. McKenzie, Lewis R. Silverman, Pierre Fenaux, Alan F. List, Eva Hellström‐Lindberg, Valeria Santini, Ghulam J. Mufti, John F. Seymour, Steven D. Gore and C.L. Beach. Their work appears in journals such as Blood, Journal of Clinical Oncology, Leukemia Research, European Journal Of Haematology and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.